BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15332628)

  • 1. Novel injectable urethral bulking agents for the treatment of urinary incontinence.
    Jordan O; Doelker E; Defabiani N; Caviezel A; Iselin C
    J Mater Sci Mater Med; 2004 Apr; 15(4):519-22. PubMed ID: 15332628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macro/Nano-gel composite as an injectable and bioactive bulking material for the treatment of urinary incontinence.
    Park KM; Son JY; Choi JH; Kim IG; Lee Y; Lee JY; Park KD
    Biomacromolecules; 2014 Jun; 15(6):1979-84. PubMed ID: 24739122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic production of bioactive fibrin micro-beads embedded in crosslinked collagen used as an injectable bulking agent for urinary incontinence treatment.
    Vardar E; Larsson HM; Allazetta S; Engelhardt EM; Pinnagoda K; Vythilingam G; Hubbell JA; Lutolf MP; Frey P
    Acta Biomater; 2018 Feb; 67():156-166. PubMed ID: 29197579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (Poly)acrylonitrile-based hydrogel as a therapeutic bulking agent in urology.
    Ramseyer P; Meagher-Villemure K; Burki M; Frey P
    Biomaterials; 2007 Feb; 28(6):1185-90. PubMed ID: 17079010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoluminal ultrasonographic and histologic evaluation of periurethral collagen injection.
    Rivas DA; Chancellor MB; Liu J-B ; Hanau C; Bagley DH; Goldberg B
    J Endourol; 1996 Feb; 10(1):61-6. PubMed ID: 8833731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraurethral bulking agents for the management of female stress urinary incontinence: a systematic review.
    Siddiqui ZA; Abboudi H; Crawford R; Shah S
    Int Urogynecol J; 2017 Sep; 28(9):1275-1284. PubMed ID: 28220200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable biomaterials for the treatment of stress urinary incontinence: their potential and pitfalls as urethral bulking agents.
    Davis NF; Kheradmand F; Creagh T
    Int Urogynecol J; 2013 Jun; 24(6):913-9. PubMed ID: 23224022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of urethral injection therapy for urinary incontinence in women: a systematic review.
    Matsuoka PK; Locali RF; Pacetta AM; Baracat EC; Haddad JM
    Clinics (Sao Paulo); 2016 Feb; 71(2):94-100. PubMed ID: 26934239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new device for the treatment of female stress urinary incontinence.
    van Veggel L; Morrell M; Harris C; Dormans-Linssen M
    Proc Inst Mech Eng H; 2003; 217(4):317-21. PubMed ID: 12885203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urethral bulking agents for female stress urinary incontinence.
    Hussain SM; Bray R
    Neurourol Urodyn; 2019 Mar; 38(3):887-892. PubMed ID: 30801773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactive porous beads as an injectable urethral bulking agent: in vivo animal study for the treatment of urinary incontinence.
    Kim IG; Oh SH; Lee JY; Lee JY; Lee JH
    Tissue Eng Part A; 2011 Jun; 17(11-12):1527-35. PubMed ID: 21275847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient Characteristics that May Influence the Effect of Urethral Injection Therapy for Female Stress Urinary Incontinence.
    Elmelund M; Sokol ER; Karram MM; Dmochowski R; Klarskov N
    J Urol; 2019 Jul; 202(1):125-131. PubMed ID: 30810462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCL microparticle-dispersed PLGA solution as a potential injectable urethral bulking agent.
    Oh SH; Lee JY; Ghil SH; Lee SS; Yuk SH; Lee JH
    Biomaterials; 2006 Mar; 27(9):1936-44. PubMed ID: 16221494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional recovery of urethra by plasmid DNA-loaded injectable agent for the treatment of urinary incontinence.
    Choi SJ; Oh SH; Kim IG; Chun SY; Lee JY; Lee JH
    Biomaterials; 2013 Jul; 34(20):4766-76. PubMed ID: 23545290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urethral bulking agents.
    McGuire EJ
    Nat Clin Pract Urol; 2006 May; 3(5):234-5. PubMed ID: 16691215
    [No Abstract]   [Full Text] [Related]  

  • 16. Urethral bulking agents: imaging review.
    Bridges MD; Petrou SP; Lightner DJ
    AJR Am J Roentgenol; 2005 Jul; 185(1):257-64. PubMed ID: 15972433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of two new injectable bulking agents for the treatment of faecal incontinence.
    Maeda Y; Vaizey CJ; Kamm MA
    Colorectal Dis; 2008 Mar; 10(3):268-72. PubMed ID: 17655723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of submucosally injected polyethylene glycol-based hydrogel and bovine cross-linked collagen in the canine urethra using cystoscopy, magnetic resonance imaging and histopathology.
    Sumner JP; Hardie RJ; Henningson JN; Drees R; Markel MD; Bjorling D
    Vet Surg; 2012 Aug; 41(6):655-63. PubMed ID: 22818023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endourethral injection of bulking agents for urinary incontinence in children.
    Godbole P; Bryant R; MacKinnon AE; Roberts JP
    BJU Int; 2003 Apr; 91(6):536-9. PubMed ID: 12656911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Submucosal injection of poly(lactic-co-glycolic acid) microspheres in rabbit bladder as a potential treatment for urinary incontinence and vesicoureteral reflux: preliminary results.
    Cho ER; Kang SW; Park HJ; Cho YS; Lee YS; Kim JC; Kim BS
    J Biomater Sci Polym Ed; 2005; 16(9):1109-20. PubMed ID: 16231602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.